PatientFi Expands Partnership with Allergan Aesthetics
The PatientFi-Allergan co-marketing agreement provides financing options for patients interested in treatments including Botox, fillers, breast implants, CoolSculpting, and DiamondGlow.
The PatientFi-Allergan co-marketing agreement provides financing options for patients interested in treatments including Botox, fillers, breast implants, CoolSculpting, and DiamondGlow.
Presentations highlight investigational trenibotulinumtoxinE in the treatment of glabellar lines and other new findings across the company's portfolio.
The regenerative biostimulator is now certified for use in four new body areas.
Allergan Aesthetics announces the U.S. FDA approval of Juvéderm Volux XC for the improvement of jawline definition in adults over the age of 21 with moderate to severe loss of jawline definition.
Read MoreCommissioned by Allergan Aesthetics, “The Future of Aesthetics” report aims to help the industry understand the developments driving today’s aesthetics market, and to highlight the key trends that may shape it in the years ahead.
Read MoreAllergan Aesthetics is celebrating Botox’s 20th anniversary as an FDA-approved product with a cross-country art installation.
Read More